APOE and Alzheimer disease: The frequency of the APOE ε4 allele in the SCI group showed a trend toward being an intermediate level between the AD/MCI and healthy control groups (SCI: 14.7%, AD: 23.6%, MCI: 21.4%, and controls: 7.3%).